Down-scheduling of CBD would unlock a huge opportunity for Creso Pharma

Special Report: Creso Pharma (ASX:CPH) says if the down-scheduling of cannabidiol goes ahead in December it would unlock a major … Read More

The post Down-scheduling of CBD would unlock a huge opportunity for Creso Pharma appeared first on Stockhead.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *